SPARK at Stanford
@sparkstanford.bsky.social
Translational research accelerator at Stanford, progressing academic innovations from bench to bedside. Unique model incorporates mentoring, education, collaboration. Visit us sparkmed.stanford.edu
SPARK at Stanford is now accepting RFPs for next year's Pilot Grants!
This is an amazing opportunity to receive mentoring, education, and support to help move academic innovations from bench to bedside. Any #Stanford affiliates are eligible. To apply, visit lnkd.in/g5WQGeeH
This is an amazing opportunity to receive mentoring, education, and support to help move academic innovations from bench to bedside. Any #Stanford affiliates are eligible. To apply, visit lnkd.in/g5WQGeeH
July 30, 2025 at 5:39 PM
SPARK at Stanford is now accepting RFPs for next year's Pilot Grants!
This is an amazing opportunity to receive mentoring, education, and support to help move academic innovations from bench to bedside. Any #Stanford affiliates are eligible. To apply, visit lnkd.in/g5WQGeeH
This is an amazing opportunity to receive mentoring, education, and support to help move academic innovations from bench to bedside. Any #Stanford affiliates are eligible. To apply, visit lnkd.in/g5WQGeeH
Reposted by SPARK at Stanford
From the $BBIO PR:
To honor the courage of our U.S. clinical trial participants, BridgeBio will provide these patients Attruby free for life
Very cool
To honor the courage of our U.S. clinical trial participants, BridgeBio will provide these patients Attruby free for life
Very cool
BridgeBio $BBIO wins FDA approval for heart disease drug
The new drug, called Attruby, will compete against medicines from Pfizer $PFE and Alnylam Pharma $ALNY
www.statnews.com/2024/11/22/b...
The new drug, called Attruby, will compete against medicines from Pfizer $PFE and Alnylam Pharma $ALNY
www.statnews.com/2024/11/22/b...
BridgeBio wins FDA approval for heart disease drug
The FDA approved a new medicine from BridgeBio for patients with ATTR-CM, a progressive heart disease
www.statnews.com
November 23, 2024 at 5:42 PM
From the $BBIO PR:
To honor the courage of our U.S. clinical trial participants, BridgeBio will provide these patients Attruby free for life
Very cool
To honor the courage of our U.S. clinical trial participants, BridgeBio will provide these patients Attruby free for life
Very cool
Reposted by SPARK at Stanford
This is the way you honor participants in clinical trials. Well done, BridgeBio: “For those who participated in the clinical trials for acoramidis (Attruby), there is exceptional news: BridgeBio is offering free access to Attruby for life to these patients in the US.” arci.org/attruby-attr...
FDA Approves Attruby™ (acoramidis) for the Treatment of ATTR-CM: A New Option for Patients
The FDA’s approval of Attruby is significant for patients with ATTR-CM, providing them with another effective treatment option.
arci.org
November 23, 2024 at 7:30 PM
This is the way you honor participants in clinical trials. Well done, BridgeBio: “For those who participated in the clinical trials for acoramidis (Attruby), there is exceptional news: BridgeBio is offering free access to Attruby for life to these patients in the US.” arci.org/attruby-attr...
SPARK supports development of innovative discoveries for rare diseases. Many patients with rare disease have limited or no options for treatment, making drug development for the more than 300 rare disease patients a critical unmet medical need. #RareDiseaseDay #RareDiseaseDay2025 #unmetmedicalneed
February 28, 2025 at 10:06 PM
SPARK supports development of innovative discoveries for rare diseases. Many patients with rare disease have limited or no options for treatment, making drug development for the more than 300 rare disease patients a critical unmet medical need. #RareDiseaseDay #RareDiseaseDay2025 #unmetmedicalneed